LINK Immunotherapeutics’ big swing at cancer
For our fourth episode, we sat down with Ashok Bandaranayake, the co-founder and VP of Immuno-Oncology at LINK Immunotherapeutics. As a spinout from Fred Hutch in Seattle, LINK’s goal is to create next-generation T-cell engaging therapies to enable durable patient responses.
Hear Ashok talk about:
How prioritizing strategic partnerships over VC funding can help you create a founder-led biotech startup
The mentors that helped him navigate spinning out a company from the Fred Hutch Cancer Center in Seattle
Why he thinks the most important part of an early startup is the team, and how they got that right
Watch now
Founder
Co-Founder LINK Immunotherapeutics at LINK Immunotherapeutics
Ashok Bandaranayake
